4,5,7-Trichlorolichexanthone
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
| Category | Others |
| Catalog number | BBF-04827 |
| CAS | |
| Molecular Weight | 389.61 |
| Molecular Formula | C16H11Cl3O5 |
Online Inquiry
Description
4,5,7-Trichlorolichexanthone is a xanthone compound.
Specification
| IUPAC Name | 2,4,5-trichloro-8-hydroxy-3,6-dimethoxy-1-methyl-9H-xanthen-9-one |
Reference Reading
1. PI(4,5)P2 controls slit diaphragm formation and endocytosis in Drosophila nephrocytes
Maximilian M Gass, Sarah Borkowsky, Marie-Luise Lotz, Rebecca Siwek, Rita Schröter, Pavel Nedvetsky, Stefan Luschnig, Astrid Rohlmann, Markus Missler, Michael P Krahn Cell Mol Life Sci. 2022 Apr 18;79(5):248. doi: 10.1007/s00018-022-04273-7.
Drosophila nephrocytes are an emerging model system for mammalian podocytes and proximal tubules as well as for the investigation of kidney diseases. Like podocytes, nephrocytes exhibit characteristics of epithelial cells, but the role of phospholipids in polarization of these cells is yet unclear. In epithelia, phosphatidylinositol(4,5)bisphosphate (PI(4,5)P2) and phosphatidylinositol(3,4,5)-trisphosphate (PI(3,4,5)P3) are asymmetrically distributed in the plasma membrane and determine apical-basal polarity. Here, we demonstrate that both phospholipids are present in the plasma membrane of nephrocytes, but only PI(4,5)P2 accumulates at slit diaphragms. Knockdown of Skittles, a phosphatidylinositol(4)phosphate 5-kinase, which produces PI(4,5)P2, abolished slit diaphragm formation and led to strongly reduced endocytosis. Notably, reduction in PI(3,4,5)P3 by overexpression of PTEN or expression of a dominant-negative phosphatidylinositol-3-kinase did not affect nephrocyte function, whereas enhanced formation of PI(3,4,5)P3 by constitutively active phosphatidylinositol-3-kinase resulted in strong slit diaphragm and endocytosis defects by ectopic activation of the Akt/mTOR pathway. Thus, PI(4,5)P2 but not PI(3,4,5)P3 is essential for slit diaphragm formation and nephrocyte function. However, PI(3,4,5)P3 has to be tightly controlled to ensure nephrocyte development.
2. A Comparative Study to Visualize PtdIns(4,5) P2 and PtdIns(3,4,5) P3 in MDA-MB-231 Breast Cancer Cell Line
Dhurgham Al-Fahad, Bandar Al-Harbi, Yahya Abbas, Firas Al-Yaseen Rep Biochem Mol Biol. 2022 Jan;10(4):518-526. doi: 10.52547/rbmb.10.4.518.
Background: Phosphatidylinositol 3,4,5-trisphosphate [PtdIns(3,4,5) P3) and Phosphatidylinositol 4,5-trisphosphate (PtdIns(4,5) P2] form an insignificant amount of phospholipids but play important roles in controlling membrane-bound signalling. Little attention has been given to visualize and monitor changes or differences in the local generation of PtdIns(4,5) P2 and PtdIns(3,4,5) P3 in the cell membranes of MDA-MB-231 breast cancer cell lines. Methods: PLCδ1-PH-GFP and Btk-PH-GFP were used as biosensors to detected PtdIns(4,5) P2 and PtdIns(3,4,5)P3 respectively. These biosensors and antibodies were transfected, immuostained and then visualized by confocal microscopy on different cell surfaces. Results: Our results showed that PLCδ1-PH-GFP/mCherry was localized at the cell membrane, while Btk-PH-GFP/mCherry was sometimes localized at the cell membrane but there was also a large amount of fluorescence present in the cytosol and nucleus. Our results also showed that the cells that expressed low levels of Btk-PH-GFP the fluorescence was predominantly localised to the cell membrane. While the cells that expressed high levels of Btk-PH-GFP the fluorescence was localization in the cytosol and cell membrane. Our results demonstrated that both anti-PtdIns(4,5)P2 and anti-PtdIns(3,4,5)P3 antibodies were localized everywhere in cell. Conclusion: Our results suggest that PLCδ1-PH-GFP and Btk-PH-GFP/mCherry have more specificity, reliability, suitability and accuracy than antibodies in binding with and detecting PtdIns(4,5)P2 and PtdIns(3,4,5)P3 and in studying the molecular dynamics of phospholipids in live and fixed cells.
3. Facile synthesis of ZnMoO4/AlPO4-5 nanorod composites as visible-light-driven photocatalysts and high-performance energy storage materials
Delvin Aman, Samira Abdel-Azim, S Said, Saad G Mohamed RSC Adv. 2022 Mar 2;12(12):7120-7132. doi: 10.1039/d2ra00268j. eCollection 2022 Mar 1.
The present article describes the facile one-step hydrothermal synthesis of single-crystalline ZnMoO4/AlPO4-5 nanorod composites. The physicochemical properties of the synthesized materials, such as structure, morphology, and bandgap, were determined using techniques such as X-ray diffraction (XRD), field emission scanning electron microscopy (FE-SEM), N2 adsorption-desorption isotherms, X-ray photoelectron (XPS), ultraviolet-visible (UV-vis), and photoluminescence (PL). The XRD pattern of synthesized ZnMoO4/AlPO4-5 verifies the synthesis of nanocomposites. Diffuse UV-vis spectra reveal that ZnMoO4/AlPO4-5 nanorod composites exhibit an indirect semiconductor with an optical bandgap between 3.15 and 3.7 eV depending on Mo : Zn ratio. In comparison to pure AlPO4-5, ZnMoO4/AlPO4-5 nanocrystal composites showed significantly higher photocatalytic activity for the degradation of para-nitrophenol (PNP, 0.04 g l-1), with 14, 99, 70, and 54% for AlPO4-5, Mo : Zn (2)/AlPO4-5, Mo : Zn (4)/AlPO4-5, and Mo : Zn (6)/AlPO4-5, respectively. This result might be attributed to the composite's efficient charge transfer and optimized electron-hole pair recombination. The supercapacitive ability of ZnMoO4/AlPO4-5 nanorod composites was also investigated in this work. For the prepared electrodes using AlPO4-5, Mo : Zn (2)/AlPO4-5, Mo : Zn (4)/AlPO4-5, and Mo : Zn (6)/AlPO4-5, the capacitance values were 400, 725, 450, and 481.25 F g-1, respectively, at a current density of 0.5 A g-1. This study shows that ZnMoO4/AlPO4-5 nanorod composites are a potential visible-light-responsive photocatalyst. The electrochemical results further demonstrate the high capacitance of ZnMoO4/AlPO4-5 nanorod composites toward energy-storage applications.
Recommended Products
| BBF-00677 | 3-Amino-3-deoxy-D-glucose | Inquiry |
| BBF-02614 | Nystatin | Inquiry |
| BBF-01826 | Deoxymannojirimycin | Inquiry |
| BBF-03753 | Baicalin | Inquiry |
| BBF-03755 | Actinomycin D | Inquiry |
| BBF-01825 | Loganin | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
* Total Molecular Weight:
g/mol
Tip: Chemical formula is case sensitive. C22H30N4O √ c22h30n40 ╳
